News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
The Food and Drug Administration on Tuesday named Dr. Vinay Prasad — a hematologist-oncologist who has been accused of ...
The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad to lead the agency’s Center for Biologics Evaluation and ...
A panel of Food and Drug Adminsitration advisers will meet May 22 to discuss updating the formula of COVID-19 vaccines ahead of the fall and winter season, according to a draft notice posted Wednesday ...
The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
(Reuters) -The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season. Later this month, the FDA will convene its external vaccine advisors to decide on the ...
If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...
Prasad has also advocated for randomized placebo-controlled trials for the Covid vaccines every year — a position the FDA, in the Trump administration, now appears to support. Dr. Buddy Creech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results